Validation Data Gallery
|Sample-dependent, check data in validation data gallery|
60126-1-Ig targets Angiotensinogen in applications and shows reactivity with human samples.
|Host / Isotype||Mouse / IgG2b|
|Immunogen||Angiotensinogen fusion protein Ag2632|
|Full Name||angiotensinogen (serpin peptidase inhibitor, clade A, member 8)|
|Calculated molecular weight||485 aa, 53 kDa|
|Observed molecular weight||52 kDa|
|GenBank accession number||BC011519|
|Gene ID (NCBI)||183|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Angiotensinogen is a precursor of angiotensin II (Ang II), is expressed and synthesized largely in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. It has a key role in mediating vascular constriction and regulating salt and fluid homeostasis. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.